IDO1 and central nervous system cancer: In GBMs, the glioma cells were observed to overexpress indoleamine 2, 3-dioxygenase (IDO) and tryptophan 2, 3-dioxygenase (TDO), which catabolize an excessive amount of tryptophan into kynurenine.